ENS@T-HT partners submitted a new patent application to develop a multi-omics signature and use of identified biomarkers to detect endocrine types of hypertension, different from primary hypertension.

Paris, 17 May 2021

Public statement

ENS@T-HT partners submitted a new patent application to

ENSAT-HT ExCom meeting November 2019

The most recent ENSAT-HT Executive Commitee meeting took place on 8th of November 2019 in Rotterdam.

ENSAT-HT first Results !

ENSAT-HT consortium meeting 2019 First results for biomakers from machine learning have been presented at the ENSAT-HT consortium in Lyon, France on 16th May 2019 by our partner University of Dundee. We also had the pleasure to welcome of two of our Scientific Advisory Board members,

Article on ENSAT-HT published in Italian newspaper

We are happy to announce that we have published a short lay public article on ENSAT‐HT in the Italian (paper) magazine Platinum, which is an inlay on science and innovation from the newspaper Il Sole 24 Ore. The article is also available online here : Article in Italian on ENSAT-HT ...

ENSAT-HT consortium meeting 2018

ENSAT-HT consortium meeting 2018 The annual ENSAT-HT consortium meeting took place in Barcelona from 17th to 18th May 2018.

New publication available

A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism Nature Genetics volume 50, pages355–361 (2018)

Authors: Fabio L. Fernandes-Rosa, Georgios Daniil, Ian J. Orozco, Corinna Göppner, Rami El Zein, Vandana Jain, Sheerazed Boulkroun, Xavier Jeunemaitre, Laurence Amar, Hervé Lefebvre, Thomas Schwarzmayr, Tim M.

Article on ENSAT-HT available on European Commission "success stories" website

We are pleased to announce that the European Commission's publication services published...